2.1000
+0.0400
+(1.94%)
At close: April 17 at 4:00:01 PM EDT
2.1000
0.00
(0.00%)
After hours: April 17 at 7:23:14 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
250
33.3510
Cost of Revenue
119.3710
119.3710
742.0480
550.8220
728.6400
Gross Profit
-119.3710
-119.3710
-742.0480
-300.8220
-695.2890
Operating Expense
9,345.6140
9,345.6140
6,932.1080
13,805.2130
12,228.9010
Operating Income
-9,464.9850
-9,464.9850
-7,674.1560
-14,106.0350
-12,924.1900
Net Non Operating Interest Income Expense
213.9750
213.9750
-49.1290
-822.6110
-904.5020
Other Income Expense
575.3200
575.3200
-185.2480
-24.6280
412.9770
Pretax Income
-8,675.6900
-8,675.6900
-7,908.5330
-14,953.2740
-13,415.7150
Tax Provision
-409.1140
-409.1140
-1,767.8030
-1,154.9350
-864.7420
Net Income Common Stockholders
-8,266.5760
-8,266.5760
-6,140.7300
-13,798.3390
-12,550.9730
Diluted NI Available to Com Stockholders
-8,266.5760
-8,266.5760
-6,140.7300
-13,798.3390
-12,550.9730
Basic EPS
-6.43
-4.98
-12.66
-76.96
-67.54
Diluted EPS
-6.43
-4.98
-12.66
-76.96
-67.54
Basic Average Shares
1,194.9730
1,660.4130
484.9950
179.4590
185.7970
Diluted Average Shares
1,194.9730
1,660.4130
484.9950
179.4590
185.7970
Total Operating Income as Reported
-9,439.4970
-9,439.4970
-7,697.9400
-14,238.9040
-13,098.9600
Total Expenses
9,464.9850
9,464.9850
7,674.1560
14,356.0350
12,957.5410
Net Income from Continuing & Discontinued Operation
-8,266.5760
-8,266.5760
-6,140.7300
-13,798.3390
-12,550.9730
Normalized Income
-8,814.7250
-8,814.7250
-5,963.3294
-13,770.1423
-12,908.5589
Interest Expense
-213.9750
-213.9750
49.1290
822.6110
904.5020
Net Interest Income
213.9750
213.9750
-49.1290
-822.6110
-904.5020
EBIT
-8,889.6650
-8,889.6650
-7,859.4040
-14,130.6630
-12,511.2130
EBITDA
-8,883.8510
-8,883.8510
-7,852.8500
-14,106.1010
-12,477.0520
Reconciled Cost of Revenue
119.3710
119.3710
742.0480
550.8220
728.6400
Reconciled Depreciation
5.8140
5.8140
6.5540
24.5620
34.1610
Net Income from Continuing Operation Net Minority Interest
-8,266.5760
-8,266.5760
-6,140.7300
-13,798.3390
-12,550.9730
Total Unusual Items Excluding Goodwill
575.2770
575.2770
-228.4710
-30.5490
382.2230
Total Unusual Items
575.2770
575.2770
-228.4710
-30.5490
382.2230
Normalized EBITDA
-9,459.1280
-9,459.1280
-7,624.3790
-14,075.5520
-12,859.2750
Tax Rate for Calcs
0
0
0.0002
0.0001
0.0001
Tax Effect of Unusual Items
27.1280
27.1280
-51.0704
-2.3523
24.6371
12/31/2021 - 4/4/1994
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MTVA MetaVia Inc.
0.7390
+0.91%
HOTH Hoth Therapeutics, Inc.
0.7876
+1.78%
ADTX Aditxt, Inc.
2.5000
+13.64%
ELAB PMGC Holdings Inc.
2.6000
+0.78%
DRMA Dermata Therapeutics, Inc.
0.7290
+1.25%
CANF Can-Fite BioPharma Ltd.
1.2000
-2.44%
PSTV Plus Therapeutics, Inc.
0.6586
-1.95%
CMND Clearmind Medicine Inc.
1.1200
+15.46%
THRD Third Harmonic Bio, Inc.
5.16
+0.58%
NLSP NLS Pharmaceutics AG
1.4600
+2.10%